Topics and Expertise: HER2

Warning message

Could not find a Solr index corresponding to your website and environment. To fix this problem, please read our documentation.

Study identifies lack of information about HER2 testing practices

Fri Oct 16, 2009
Phillips
Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...